Desmopressin ODT Has Similar Efficacy in Nocturia Patients With OAB
Desmopressin orally disintegrating tablets resulted in declines in nocturnal voids in men and women with nocturnal polyuria and mild daytime voiding dysfunction.
ICS 2018 Coverage
In-Hospital Falls Often Linked to Nocturnal Toileting
In a study, 28% of all incident in-hospital falls were associated with nighttime visits to the toilet.
Nocturnal Polyuria Common in Women with OAB
In a study, nocturnal polyuria was present in 30% of women with overactive bladder.
Prazosin May Lower Prostate Cancer Recurrence Risk After Radiotherapy
LUTS treatment with the alpha-blocker prazosin was associated with significantly lower 2- and 5-year biochemical recurrence rates vs tamsulosin and non-use of alpha-blockers.
Worse Nocturia Found in Men Taking Multiple BP Drugs
Taking 2 or more drugs for hypertension is associated with a significantly higher number of nocturnal voids and higher nocturnal polyuria index, study finds.
Mirabegron Safe, Effective for Overactive Bladder in the Elderly
Phase 4 trial showed that mirabegron significantly decreased incontinence episodes and micturitions compared with placebo among patients aged 65 years and older.
Socioeconomic Factors May Affect Advanced OAB Therapy Use
A study of commercially insured patients showed Asians and Hispanics were less likely than whites to undergo advanced overactive bladder treatments.
Possible Overactive Bladder Biomarkers Identified in Men
Study suggests male OAB could be associated with abnormalities in metabolic pathways of fatty acids and bile acids.
Pre-Diabetes Ups Overactive Bladder Risk in Women
Even modestly elevated fasting plasma glucose levels and HbA1c is associated with increased odds of overactive bladder.
Overactive Bladder Risk Linked to Visceral Fat
The ratio of visceral fat volume to total abdominal fat volume is an independent risk factor for overactive bladder, study finds.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in ICS 2018 Coverage
Loading... 
Loading...